Skip Navigation

The event ended, check back after it has been posted to the Past Events section.

Translational Sciences in Oncology: To the Clinic and back againHHS Only

Air date: Friday, May 6, 2016, 12:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Description: NCI Center for Cancer Research Grand Rounds

Dr. J. Carl Barrett is Vice President of Translational Science in Oncology at AstraZeneca. He is responsible for development and execution of biomarker strategies and translational sciences efforts to support compound development from research through early and full development in oncology. From 2005-2011, he was Global Head of Oncology Biomarkers and Imaging at Novartis. Dr. Barrett was the founding Director of the NCI Center for Cancer Research (CCR), the NCI intramural center for translation medicine. He was also Scientific Director at the National Institute of Environmental Health Sciences where he focused on integrating new approaches to toxicogenomics, molecular toxicology, and the Environmental Genome Project.

Dr. Barrett’s research focused on the discovery of the critical genetic and epigenetic changes in the cancer cell, in particular the discovery of genes involved in breast cancer (BRCA1). Trained as a chemist at the College of William and Mary, he received his Ph.D. degree in Biophysical Chemistry from Johns Hopkins University. He has published over 600 research articles. He is a member of the Johns Hopkins University Society of Scholars, the Ramazini Foundation, an honorary member of the Japanese Cancer Association, and a recipient of multiple NIH awards and Keynote lectures.
Author: J. Carl Barrett, Ph.D., Vice-president, Translational Science, Oncology Innovative Medicine, AstraZeneca Pharmaceuticals LP
Runtime: 1 hour